FOSTER CITY, Calif.--(BUSINESS WIRE)--Entelos, Inc. (LSE:ENTL), a leading life sciences company building predictive computer models of human physiology and “virtual patients” for drug discovery and development, announces today that because two of its customers have reprioritized their internal clinical programs, there will be a decrease in the expected revenue for 2007. Revenue guidance for 2006 remains unchanged.
